Financial Daily from THE HINDU group of publications
Friday, Apr 01, 2005

News
Features
Stocks
Port Info
Archives
Google

Group Sites

Corporate - Regulatory Bodies & Rulings


J&J sends interim response to FDA

Our Bureau

Mumbai , March 31

JOHNSON & Johnson (J&J) has sent an interim response to the Maharashtra Food and Drug Administration (FDA) seeking more time to respond to the regulatory authority's concerns on J&J's oil for infants.

This comes even as the FDA's 15-day deadline to respond to the show-cause notice sent by it expired on March 31.

The FDA has given the multinational company 15 more days to respond to the show-cause notice, an official familiar with the J&J related developments told Business Line. The regulatory authority had also visited the company's facility in Mulund, in Mumbai's suburb, the official said.

Earlier this month, the FDA had issued a show-cause notice to J&J asking the company to drop "baby" from its label. The regulatory authority had expressed concern over whether the mineral oil used in the product was unfit for babies.

Following this development, Chinese authorities too had put J&J's baby oil under the scanner. After investigations, however, they cleared the products in question, stating that they met the requirements, news reports said. Meanwhile, the FDA has also sent a similar notice to Wipro on its baby oil.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page


Stories in this Section
Benz Auto changes name to Focuz


Raymond to invest Rs 100 cr in denim
Mahanagar Gas to expand presence — Plans Rs 250-cr capex
Natco allots shares to FCCB holders
ICSI permits members to take up other activities
HC okays demerger of Suryalakshmi mills' yarn division
Ucal Fuel to buy AMTEC of US
Shareholders angry over BPCL-Kochi Refineries merger swap ratio
Opto Circuits to buy US co through GDR proceeds
Steel Ministry to back SAIL for stake in Neelachal Ispat
Goa Carbon to merge with Paradeep Carbons
`Good corporate governance is good business'
`Money spent on corporate governance compliance is investment'
J&J sends interim response to FDA
Our contract manufacturer will respond to FDA notice: Wipro
Tata gift for cancer research institute in AP
GV Films proposes Rs 42-cr rights issue
Pennar Profiles gets lenders' nod for OTS scheme
Sashi Kumar is Coal India chief
O.P. Jindal killed in copter crash in UP


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line